CONMED Corp. (CNMD)
- On 1:00 am EDT, Wednesday October 21, 2009
Conmed Corp. (NasdaqGS: CNMD - News) operates in highly competitive markets against competitors that are much larger, technically competent and possess substantially more assets.
Additionally, many of these competitors offer a range of products not matched by Conmed, which may make Conmed's offerings less attractive to surgeons, hospitals, and group purchasing organizations that are trying to reduce the number of vendors they do business with. In the second quarter, earnings per share were $0.17, compared to the Zacks Consensus Estimate of $0.16 and the year-ago earnings of $0.43.
We have an Underperform rating on Conmed with a target price of $18.
CONMED CORP (CNMD): Free Stock Analysis Report
|
Related Headlines
- CONMED Corporation to Present at the 21st Annual Piper Jaffray Health Care Conference - Marketwire
- CONMED Linvatec Announces Launch of Novel Biocomposite Technology and Related Matryx(TM) Biocomposite Interference Screws - Marketwire
- CONMED Linvatec Announces Launch of Bullseye(TM) Anatomic Cruciate Reconstruction System - Marketwire
- CONMED CORP Financials - EDGAR Online Financials
- CONMED CORP Files SEC form 10-Q, Quarterly Report - EDGAR Online
Related Blog Headlines
- Stryker Strikes Acquisition Deals - Zacks.com
- Zacks #1 Rank Additions for Tuesday - Zacks.com
- Hanger Beats Zacks Estimates - Zacks.com
- Conmed Surpasses Zacks Estimate - Zacks.com
- Stryker Meets Expectations - Zacks.com
Sponsored Links
-
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial. -
2.00-2.30% Apply Online
From AA+ Rated GE Capital Corp. Not An Offer Of Securities For Sale.
-
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month. -
Need Affordable Health Care?
Get Affordable Health Insurance Quotes Online - Rates from $30 / Month
More From Provider
Tech Ticker Recent Posts
Add Alert © 2009 Zacks.com. All rights reserved.